Original Article
Neuropsychopharmacology (2004) 29, 2258–2265, advance online publication, 13 October 2004; doi:10.1038/sj.npp.1300556
Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression
Carolyn Cidis Meltzer1,2,3, Julie C Price1, Chester A Mathis1, Meryl A Butters2, Scott K Ziolko1, Eydie Moses-Kolko2, Sati Mazumdar2,4, Benoit H Mulsant2, Patricia R Houck2, Brian J Lopresti1, Lisa A Weissfeld4 and Charles F Reynolds2,3,5
- 1Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA
- 2Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
- 3Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
- 4Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA
- 5Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA
Correspondence: CC Meltzer, University of Pittsburgh Medical Center, PUH D-132, 200 Lothrop Street, Pittsburgh, PA 15213-2582, USA. Tel: +1 412 647 3553; Fax: +1 412 647 0738; E-mail: meltzercc@msx.upmc.edu
Received 14 December 2003; Revised 24 March 2004; Accepted 11 May 2004; Published online 13 October 2004.
Abstract
Depression in late life carries an increased risk of dementia and brittle response to treatment. There is growing evidence to support a key role of the serotonin type 1A (5-HT1A) receptor as a regulator of treatment response, particularly the 5-HT1A autoreceptor in the dorsal raphe nucleus (DRN). We used [11C]WAY 100635 and positron emission tomography (PET) to test our hypothesis that 5-HT1A receptor binding in the DRN and prefrontal cortex is altered in elderly depressives and that these measures relate to treatment responsivity. We studied 17 elderly subjects with untreated (nonpsychotic, nonbipolar) major depression (four men, 13 women; mean age: 71.4
5.9) and 17 healthy control subjects (eight men, nine women; mean age: 70.0
6.7). Patients were subsequently treated with paroxetine as part of a clinical trial of maintenance therapies in geriatric depression. [11C]WAY 100635 PET imaging was acquired and binding potential (BP) values derived using compartmental modeling. We observed significantly diminished [11C]WAY 100635 binding in the DRN in depressed (BP=2.31
0.90) relative to control (BP=3.69
1.56) subjects (p=0.0016). Further, the DRN BP was correlated with pretreatment Hamilton Depression Rating Scores (r=0.60, p=0.014) in the depressed cohort. A trend level correlation between DRN binding and time to remission (r=0.52, p=0.067) was observed in the 14 depressed patients for whom these data were available. Our finding of decreased [11C]WAY 100635 binding in the brainstem region of the DRN in elderly depressed patients supports evidence of altered 5-HT1A autoreceptor function in depression. Further, this work indicates that dysfunction in autoreceptor activity may play a central role in the mechanisms underlying treatment response to selective serotonin reuptake inhibitors in late-life depression.
Keywords:
depression, serotonin, brain, emission tomography
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Journal of Cerebral Blood Flow & Metabolism Original Article
Journal of Cerebral Blood Flow & Metabolism Original Article

